7630 — IMPACT Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- HK$2.94bn
- HK$2.99bn
- CNY38.25m
Annual balance sheet for IMPACT Therapeutics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 340 | 259 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 0 | 7.44 |
| Total Inventory | ||
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 374 | 323 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 9.19 | 5.96 |
| Net Intangible Assets | ||
| Other Long Term Assets | ||
| Total Assets | 389 | 335 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 89.5 | 105 |
| Long Term Debt | ||
| Capital Lease Obligations | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 1,133 | 1,292 |
| Common Stock | ||
| Retained Earnings (Accumulated Deficit) | ||
| Other Equity | ||
| Total Equity | -744 | -958 |
| Total Liabilities & Shareholders' Equity | 389 | 335 |
| Total Common Shares Outstanding |